Skip to content

Innoviva, Inc. INVA Debt Repayments

Debt Repayments at other companies

Merck & Co. logo
Merck & Co.MRK
$1.14B-54.4%
Organon logo
OrganonOGN
$32M-65.6%
LQD
Liquidia CorporationLQDA
$19.97M+841%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$4.06M+100%
United Therapeutics logo
United TherapeuticsUTHR
$0-100%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$1.7M+4.1%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfUnsecuredDebt.

The official record: Innoviva, Inc.’s 10-K, filed February 26, 2025, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s debt repayments?
Innoviva, Inc. (INVA) reported debt repayments of $0 in Q4 2024.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.